English | Español

Biospace
Patient Daily | Dec 19, 2025

Johnson & Johnson receives FDA priority voucher for multiple myeloma drug combination
Patient Daily | Dec 19, 2025

FDA approves first-line use of Enhertu for metastatic HER2-positive breast cancer
Patient Daily | Dec 19, 2025

Ambros raises $125M to bring Italian non-opioid pain drug to U.S. market
Patient Daily | Dec 19, 2025

Sanofi partners with South Korea's ADEL in $1B+ Alzheimer's drug development deal
Patient Daily | Dec 19, 2025

Analysts identify six biotechs as potential big pharma acquisition targets
Patient Daily | Dec 19, 2025

Lilly posts strong weight loss trial results; FDA denies black box plan for COVID vaccines
Patient Daily | Dec 19, 2025

Bristol Myers Squibb partners with Harbour BioMed on multi-specific antibody therapies
Patient Daily | Dec 19, 2025

GSK receives FDA approval for new biologic therapy targeting severe eosinophilic asthma

Trending
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Rare disease drug developers outline strategies at J.P. Morgan Healthcare conference
+ Pharmaceuticals
Patient Daily | Jan 30, 2026

Senate gridlock delays decision on rare disease priority review voucher program
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

SpyGlass Pharma and AgomAb Therapeutics file for Nasdaq IPOs
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Clinical trial landscape shifts globally as China increases role in innovation